Clinical Trial Update: Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a low-dose immune tolerance induction strategy for children with Hemophilia A and inhibitors who are at high risk for poo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Beijing Children's Hospital | Conditions: Hemophilia A With Inhibitor | Phase 4 | Status: UNKNOWN